Investors Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases Overview Stock Information Stock Quote & Chart Historical Price Lookup Stock Calculator News & Events News Releases Investor Calendar Presentations Financial Information SEC Filings Annual Reports Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Investor Resources Email Alerts Contact IR Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases Committee Composition Director Name Audit BOD Chair Compensation Lead Independent Director Nom & Corp Gov Steven Gillis, Ph.D. chairperson of Nom & Corp Gov Matthew R. Patterson member of Audit Jeff Poulton member of Audit member of Lead Independent Director Alise Reicin, M.D. chairperson of Compensation member of Nom & Corp Gov Mary Thistle Financial Expert chairperson of Audit member of Compensation Arthur Tzianabos, Ph.D. chairperson of BOD Chair Legend = Chairperson = Member = Financial Expert
Director Name Audit BOD Chair Compensation Lead Independent Director Nom & Corp Gov Steven Gillis, Ph.D. chairperson of Nom & Corp Gov Matthew R. Patterson member of Audit Jeff Poulton member of Audit member of Lead Independent Director Alise Reicin, M.D. chairperson of Compensation member of Nom & Corp Gov Mary Thistle Financial Expert chairperson of Audit member of Compensation Arthur Tzianabos, Ph.D. chairperson of BOD Chair Legend = Chairperson = Member = Financial Expert